F-1: Lytus Technologies F-1: IPO & NYSE Uplist Bid

Lytus Technologies Holdings PTV. Ltd. files an F-1 registration statement for a public offering of 1,111,112 common shares, targeting a NYSE listing and a 1-for-1,000 reverse stock split.

Summary

• Lytus Technologies Holdings PTV. Ltd. is offering 1,111,112 common shares in a firm commitment underwritten public offering, with an expected price between $8.00 and $10.00 per share, assuming a 1-for-1,000 reverse stock split.
• The company intends to apply for listing on NYSE under the symbol LYT, contingent on the offering's consummation, following a board-approved 1-for-1,000 reverse stock split on September 12, 2025.
• Estimated net proceeds of approximately $9.7 million from the offering are allocated: $1.6 million to repay a promissory note to Yorkville and $8.4 million for working capital and general corporate purposes, including potential strategic transactions.
• The company operates primarily in India, providing linear content streaming/telecasting services and developing healthtech and fintech products, with over four million active users.
• For the fiscal year ended March 31, 2025, total revenue increased by 0.80% to $23,186,534, and net income after tax rose by 27% to $829,412.
• Dharmesh Pandya, the CEO, beneficially owns approximately 78% of outstanding common shares prior to the offering and 64% after, maintaining substantial control.
• As an emerging growth company and foreign private issuer, Lytus benefits from reduced public company reporting requirements and exemptions from certain U.S. corporate governance standards.

Sentiment

Score: 3

Explanation: While there is some revenue growth and strategic expansion plans, the delisting from Nasdaq, material weaknesses in internal controls, and significant dilution for new investors are major red flags. The positive financial metrics are overshadowed by these serious issues and risks, indicating a high degree of investment risk.

Positives

• Net income after tax increased by 27% to $829,412 for the fiscal year ended March 31, 2025, compared to $653,174 in the prior year.
• Operating revenue grew by 8.26% to $23,127,919 for the fiscal year ended March 31, 2025, primarily driven by increases in carriage and placement fees and consultancy services.
• Finance costs significantly decreased by 77% to $149,171 for the fiscal year ended March 31, 2025, due to repayment of borrowings and extinguishment of warrant liabilities.
• The company possesses a strong customer base of over four million active users in India, providing a foundation for expanding future technology services like healthtech and fintech.
• Strategic initiatives include upgrading existing cable networks to Fiber to the Home (FTTH) and Gigabit Passive Optical Networks (GPON) to offer additional value-added services and enhance customer experience.
• Lytus has obtained an Internet Service Provider License, enabling it to offer broadband/internet services alongside traditional cable services, which is expected to boost revenues and customer loyalty.
• Management anticipates that the proceeds from this offering will be sufficient to cover the company's cash needs for the next 12 months.
• The company is developing Lytus Studios to produce original content for its streaming platform, funded by operational cash flow and future offerings.

Negatives

• The company's common shares were delisted from Nasdaq on March 31, 2025, due to non-compliance with Nasdaq Listing Rule 5550(a)(2), and now trade on the OTCQB tier.
• Other income decreased significantly by 96.42% to $58,615 for the fiscal year ended March 31, 2025, mainly due to a non-recurring write-off of warrant liability in the prior year.
• Subscription income, a core revenue stream, decreased by 4.34% to $14,305,443 for the fiscal year ended March 31, 2025.
• Fiber use revenue decreased by 100% to $0 for the fiscal year ended March 31, 2025.
• Material weaknesses in internal control over financial reporting and ineffective disclosure controls and procedures were identified as of March 31, 2025.
• Investors in this offering will experience immediate and substantial dilution of $8.82 per share, based on an assumed public offering price of $9.00 per share.
• The company does not plan to pay dividends in the foreseeable future, retaining all available funds for business operations and expansion.
• A legal proceeding against CEO Dharmesh Pandya, alleging breach of contract and fiduciary duty with claims of $854,000 in damages, is ongoing.

Risks

• An active public trading market for common shares may not develop or be sustained, potentially limiting liquidity.
• Current quotation on OTCQB may negatively impact stock price and liquidity; there is no guarantee of NYSE listing approval or ability to satisfy ongoing listing requirements.
• The Reverse Stock Split may decrease the liquidity of common shares and may not attract new investors or improve trading liquidity.
• U.S. broker-dealers may be discouraged from effecting transactions in common shares if they are considered 'penny stock' (under $5.00 per share), limiting market liquidity.
• Substantial future sales of common shares or the perception of such sales may depress the stock price and cause dilution.
• Management has broad discretion in the use of net proceeds from the offering, which may not yield a favorable return on investment.
• Investors in this offering will experience immediate and substantial dilution.
• The common share price could continue to be volatile, leading to potential loss of investment value.
• As a foreign private issuer, disclosure obligations differ from U.S. domestic reporting companies, potentially making it harder for investors to evaluate performance.
• Being a 'controlled company' under NYSE rules (if listed) allows reliance on exemptions from certain corporate governance requirements, affording less protection to shareholders.
• Officers, directors, and principal shareholders own a significant percentage (78% pre-offering, 64% post-offering) of common shares, exerting substantial control over shareholder approval matters.
• Dilution may result from the conversion of outstanding promissory notes (e.g., Yorkville's Note convertible at $50.00 per share, subject to adjustment).
• Rights of shareholders under BVI law differ from U.S. law, potentially offering fewer protections.
• Risk of becoming a passive foreign investment company (PFIC), which could result in adverse U.S. tax consequences for U.S. investors.
• Limited operating history and rapid growth make evaluating current business and future prospects difficult and increase investment risk.
• Revenues and expenses are difficult to predict, increasing the likelihood of results falling below expectations.
• Risks related to storage of confidential information and cybersecurity incidents could harm business and expose to liability.
• Economic slowdowns or factors affecting the economic health of the U.S., India, or the IT, healthcare, and streaming industries may adversely affect the business.
• Liability issues inherent to the healthcare industry, with expensive and difficult-to-obtain insurance.
• Failure to develop and maintain effective internal control over financial reporting and disclosure controls and procedures could lead to inaccurate financial reporting.
• Reliance on information technology; failure to adapt to technological developments or industry trends could harm the business.
• Reliance on third-party systems and service providers; disruptions or adverse changes could materially affect the business.
• Potential intellectual property infringement claims, which may be expensive to defend and disrupt operations.
• Platform and internal systems rely on highly technical software that may contain undetected errors.
• Dependence on maintaining relationships with business partners and other third parties.
• No plans to pay dividends in the foreseeable future.
• Substantial portion of business and operations in India, subject to regulatory, economic, social, and political uncertainties.
• Restrictions on foreign investment in India may prevent future acquisitions or investments.
• Business and activities regulated by The Competition Act, 2002 in India.
• Healthcare industry in India is subject to extensive laws, rules, and regulations.
• Infrastructure in India may not be upgraded to support higher internet penetration, requiring additional investments.
• Results of operations are subject to fluctuations in currency exchange rates.
• Inability to obtain additional financing on acceptable terms, if needed.
• Operating in highly competitive industries (streaming, telemedicine, fintech).
• Inability to recruit and retain experienced therapists for the healthcare segment.
• Healthcare provider licensing and credentialing can negatively impact margins.
• Failure to successfully implement growth strategies.
• Inability to identify and exploit new market opportunities.
• Difficult market conditions, economic conditions, and geopolitical uncertainties could adversely affect business.
• Changing laws, rules, and regulations, including adverse tax law applications, may affect business.

Future Outlook

The company plans to expand its service and product portfolio, enhance its technology platform, and enter new geographic markets, particularly in India. It aims to launch subscription-based remote patient monitoring devices in Telangana, India, in the second half of 2025, and similar devices in the United States via Lytus Health. The rollout of local health centers and diagnostic centers through Lytus India is expected to commence in the second half of 2025 and take 24 months to complete. Fintech services, starting with e-wallet payments for Sri Sai customers, are also planned for expansion to include credit cards and microloans. Lytus Studios intends to produce original content for the Lytus Play streaming platform. These initiatives are expected to be funded through operational cash flow, vendor financing, customer deposits, existing credit lines, and future securities offerings.

Management Comments

• "We are focused on consolidating our subscriber base for future technology services, such as healthtech and fintech services, while continuing to develop our technology platform for a better service experience."
• "We believe that our strong customer base and expansive market presence position us to expand our portfolio of offerings."
• "We believe that our deep understanding and local expertise have enabled us to create solutions that address the needs and preferences of our consumers in the most comprehensive and efficient way."
• "Management believes that the proceeds from this offering will be sufficient to satisfy the Company’s cash needs for the next 12 months."
• "We intend to vigorously protect our technology and proprietary rights, but there can be no assurance that our efforts will be successful."
• "Although the outcomes of legal proceedings are inherently difficult to predict, we are not currently involved in any legal proceeding in which the outcome, in our judgment based on information currently available, is likely to have a material adverse effect on our business or financial position."
• "We believe the Plaintiffs claims [against Mr. Pandya] are false and frivolous and are in response to a lawsuit filed by Nextecworks in the UK against the plaintiffs for $40 million dollars for fraudulent misrepresentation, breach of contract and illegally holding onto 1% of the equity of Nextecworks."
• "Our Board has not adopted policies imposing an arbitrary term or retirement age limit in connection with individuals serving as directors as it does not believe that such a limit is in the best interests of our company."

Industry Context

Lytus Technologies operates in the rapidly evolving Indian streaming, telemedicine, and fintech markets. The streaming sector is experiencing growth due to increasing internet penetration and demand for video-on-demand (VoD) services, with major competitors like JioHotstar, Netflix, and Olly Plus. The Indian government's digital transformation initiatives, such as cable TV digitization, are favorable. In telemedicine, Lytus aims to address unmet medical needs in rural India, leveraging increasing internet access and technology for preventive healthcare and remote consultations, competing with platforms like Practo, 1mg, and Apollo 24/7. The fintech segment seeks to capitalize on India's e-commerce boom by converting cash collections to e-wallet payments and offering microloans, facing competition from Amazon Pay, Ola Money, and JioMoney. The company's strategy aligns with these trends by upgrading infrastructure (Fiber to the Home, GPON), developing AI/ML capabilities for healthcare, and expanding its integrated platform.

Comparison to Industry Standards

• Streaming: The company's strategy to upgrade existing cable networks to Fiber to the Home (FTTH) and Gigabit Passive Optical Networks (GPON) aligns with global trends in broadband modernization and enhanced content delivery, similar to major telecom and cable operators worldwide. Its offering of 450+ linear channels is competitive within the Indian market, which is seeing significant growth in OTT platforms like JioHotstar (300 million users), Netflix, and regional players.
• Telemedicine: Lytus's plan to repurpose local cable operator (LCO) networks for local health and diagnostic centers (LHCs) and distribute remote patient monitoring devices is an innovative approach to last-mile healthcare delivery in rural India. This model could potentially reach underserved populations more effectively than traditional telemedicine platforms like Practo, 1mg, and Apollo 24/7, which primarily focus on online consultations. The emphasis on HIPAA and FDA compliant devices for the U.S. market indicates an adherence to international healthcare standards.
• Fintech: The initial focus on converting cash collections to e-wallet payments for existing cable customers is a practical step to integrate financial services within its established user base. This strategy is comparable to how large tech companies (e.g., Amazon Pay, JioMoney) leverage their ecosystems to offer financial products, aiming for a 'one-stop shop' experience. The eventual plan to offer credit cards and microloans positions Lytus to compete with established digital payment and lending platforms.
• Subscriber Base: The company's calculation of 'four million active users' based on 1 million paid home subscribers and an industry average of 4.4 users per household in India is a common method for estimating reach in the media industry, though it carries inherent assumptions.
• Corporate Governance: As a foreign private issuer and a controlled company, Lytus benefits from exemptions from certain NYSE corporate governance rules (e.g., majority independent board, independent compensation/nominating committees). This deviates from the stricter governance standards typically applied to U.S. domestic issuers, which might be viewed as less protective for shareholders.

Management Changes

Corporate Governance

Legal Proceedings

• A complaint filed on May 22, 2020, in Florida against CEO Dharmesh Pandya by Securitax Ltd. and Optimal US Logistics, LLC, alleging breach of contract and breach of fiduciary duty, claiming $854,000 in damages. Mr. Pandya is actively defending these claims, which the company believes are false and frivolous. Mediation is ongoing.
• On April 11, 2023, an arbitrator awarded final damages of $130,000 plus legal and other incidental expenses, aggregating to $260,000, in favor of Skyline Corporate Communications Group, LLC against the Company due to non-payment under a contract.

Related Party Transactions

• Subscription income of $518,795 from significant influence entities (KMP) in FY2025.
• STB Installation charges of $48,445 from significant influence entities (KMP) in FY2025.
• Loan taken of $272,365 from KMP and $1,850,313 from significant influence entities (KMP) in FY2024. Additionally, $124,918 from relatives of KMP in FY2024.
• Loan repayment of $1,543,653 to KMP and $912,506 to significant influence entities (KMP) in FY2025. Also, $19,012 to relatives of KMP in FY2025.
• Commission expenses of $1,305,186 from significant influence entities (KMP) in FY2025.
• Bandwidth charges of $24,339 from significant influence entities (KMP) in FY2025.
• Sales/Purchase of materials of $8,602 from significant influence entities (KMP) in FY2025.
• Fiber Maintenance Expense of $1,502 from significant influence entities (KMP) in FY2025.
• Consultancy Services (Revenue) of $1,061,622 from significant influence entities (KMP) in FY2025.
• IT Support Charges of $5,908 from significant influence entities (KMP) in FY2025.
• Remuneration of $141,797 to KMP and $38,286 to relatives of KMP in FY2025.
• Rent paid/provided of $7,802 to KMP in FY2025.
• Interest on loan of $212 to significant influence entities (KMP) in FY2025.
• Investment in CCD of Subsidiary of $3,817,490 in FY2025.
• Reimbursement of expenses of $92,246 to KMP in FY2025.
• Loans and Advances Given of $239,684 to significant influence entities (KMP) and $97,355 to relatives of KMP in FY2024.
• Loans and Advances Received Back of $214,458 from KMP in FY2025.
• Advances for Network Acquisition of $16,661 from significant influence entities (KMP) in FY2025.
• Outstanding loan payable of $164,124 to directors and $31,019 to a related party in FY2024.
• Outstanding loan receivable of $35,598 from significant influence entities (KMP) and $95,443 from relatives of KMP in FY2024.
• Outstanding options of $91,813 to significant influence entities (KMP) in FY2025.
• Issuance of 3,800,000,000 restricted common shares to the Lytus Trust (controlled by CEO Dharmesh Pandya) on July 3, 2025, for future allocation to management and/or employees.

Stakeholder Impact

• Shareholders: Will experience immediate and substantial dilution from the offering ($8.82 per share). Existing shareholders, particularly Dharmesh Pandya and the Lytus Trust, will retain significant control (64% post-offering). The delisting from Nasdaq and trading on OTCQB may negatively impact liquidity and stock price. Future capital raises could lead to further dilution.
• Employees: The 2023 Employee Incentive Plan and the issuance of 3,800,000,000 restricted common shares to the Lytus Trust for future allocation to management and/or employees aim to attract, retain, and motivate personnel. However, 300,000 unvested shares were cancelled due to breach of service conditions.
• Customers: The company's strategy to upgrade cable networks, expand into healthtech and fintech, and offer a wider range of online services aims to enhance customer experience and provide multi-dimensional services, potentially increasing customer loyalty.
• Creditors: Repayment of the $1.6 million promissory note to Yorkville will reduce current debt obligations. However, the company's overall debt remains substantial ($13,359,764 current debt as of March 31, 2025).
• Regulatory Bodies: The company is subject to extensive governmental laws and regulations in India and the U.S., particularly in telecommunications, healthcare, and financial services. Non-compliance or changes in regulations could lead to penalties or operational restrictions.

Next Steps

• Effectuate a 1-for-1,000 reverse stock split prior to the consummation of the public offering.
• Apply to list common shares on NYSE under the symbol LYT.
• Price the common shares to be offered and sold in connection with the public offering.
• Uplist common shares to NYSE (contingent on approval).
• Repay approximately $1.6 million outstanding under the promissory note to Yorkville.
• Utilize approximately $8.4 million for working capital and general corporate purposes, including potential strategic transactions.
• Launch subscription-based remote patient monitoring devices in Telangana, India, in the second half of 2025.
• Purchase and install patient monitoring devices in the United States via Lytus Health in the second half of 2025.
• Commence rollout of local health centers and diagnostic centers in India in the second half of 2025 (expected to take 24 months).
• Initially offer Fintech services to Sri Sai customers, focusing on converting cash collections to e-wallet payments.
• Expand Fintech services to include credit cards and microloans to subscribers.
• Continue to develop and enhance the unified, scalable technology platform.
• Produce original content for the Lytus Play streaming platform through Lytus Studios.
• Complete the acquisition of 51% of Sreedevi Digital Systems Private Limited (subsequent to reporting date).
• Address and remediate identified material weaknesses in internal control over financial reporting and ineffective disclosure controls and procedures.
• The independent compensation committee is expected to hold its next meeting on or before September 30, 2025, to confirm executive compensation.
• CEO Dharmesh Pandya's attorneys are continuing to mediate to settle the legal case against him.

Key Dates

Recommendation

The delisting from Nasdaq due to non-compliance is a severe negative event, indicating significant operational or financial issues. While the company is attempting to uplist to NYSE, there's no guarantee of approval, and trading on OTCQB typically implies lower liquidity and investor confidence. The immediate and substantial dilution for new investors ($8.82 per share on a $9.00 offering price) is highly unfavorable. Furthermore, the identified material weaknesses in internal controls and ineffective disclosure procedures raise serious concerns about financial reporting reliability and corporate governance. The ongoing legal proceeding against the CEO adds another layer of uncertainty. Despite some revenue growth and strategic expansion plans, these fundamental issues present a high degree of risk and suggest a 'sell' recommendation for existing holders and avoidance for new investors until these critical issues are resolved and sustained operational stability is demonstrated.

Keywords

Lytus Technologies, F-1 filing, IPO, NYSE listing, Reverse Stock Split, India market, streaming services, telemedicine, fintech, SEC filing, public offering, corporate governance, risk factors, financial performance, emerging growth company, foreign private issuer, capital raise, Dharmesh Pandya, Sri Sai Networks, broadband, OTT platform, healthcare technology, financial technology, equity offering, market volatility, regulatory compliance, share dilution